CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 59 filers reported holding CATABASIS PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $9,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 300,000 | $1,311,000 | 1.26% |
| Stonepine Capital Management, LLC | 41,688 | $182,000 | 0.16% |
| Alyeska Investment Group, L.P. | 1,000,000 | $4,370,000 | 0.06% |
| FEDERATED HERMES, INC. | 1,043,400 | $4,560,000 | 0.01% |
| OPPENHEIMER & CO INC | 46,581 | $203,000 | 0.01% |
| Blackstone Inc. | 200,819 | $878,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 33,743 | $147,000 | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 2,000 | $9,000 | 0.00% |
| NORTHERN TRUST CORP | 16,748 | $73,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 8,289 | $36,000 | 0.00% |